Page last updated: 2024-12-09

hc 030031

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide: a TRPA1 channel blocker [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1150897
CHEMBL ID1086310
SCHEMBL ID1064155
MeSH IDM0550873

Synonyms (50)

Synonym
OPREA1_280240
OPREA1_427263
STK096101
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)-n-[4-(propan-2-yl)phenyl]acetamide
AKOS001460528
FT-0669107
CHEMBL1086310 ,
2-(1,3-dimethyl-2,6-dioxo-2,3-dihydro-1h-purin-7(6h)-yl)-n-(4-isopropylphenyl)acetamide
bdbm50318463
349085-38-7
2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-n-(4-propan-2-ylphenyl)acetamide
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)-n-(4-isopropylphenyl)acetamide
hc-030031
hc 030031
hc030031
HY-15064
CS-1040
S2918
2-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1h-purin-7-yl)-n-[4-(propan-2-yl)phenyl]acetamide
gtpl4211
SCHEMBL1064155
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-yl)-n-(4-isopropylphenyl)acetamide
c18h21n5o3
HB1158
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)-n-(4-isopropylphenyl)acet amide
AC-32672
DTXSID10360763
hc-030031, >=98% (hplc), powder
HMS3651P10
toslab 829227
AS-74408
J-019797
NCGC00378740-04
SW131228-2
BCP06674
trpa1 antagonist, hc-030031 - cas 349085-38-7
Z19358150
mfcd02007349
EX-A2393
Q27077969
HMS3884P22
HMS3742O17
CCG-268098
H11006
H-105
2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-n-(4-propan-2-ylphenyl)acetamide.
7h-purine-7-acetamide, 1,2,3,6-tetrahydro-1,3-dimethyl-n-(4-(1-methylethyl)phenyl)-2,6-dioxo-
mu78vfh9c7 ,
unii-mu78vfh9c7
EN300-41480

Research Excerpts

Treatment

ExcerptReferenceRelevance
"The treatment with HC 030031 either before (100 mg/kg, p.o.) or after (30 mg/kg, i.v.) cyclophosphamide inhibited the non-voiding contractions but failed to counteract the loss in voiding efficiency."( Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis.
Calixto, JB; Forner, S; Lima-Garcia, JF; Meotti, FC; Viana, AF, 2013
)
0.71

Bioavailability

ExcerptReferenceRelevance
"015 μM), which has moderate oral bioavailability in rodents and demonstrates robust activity in vivo in several rodent models of inflammatory pain."( Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.
Boissel, V; D'Souza, AM; Devereux, N; Head, V; Lao, J; Masick, B; Nash, M; Panesar, M; Patapoutian, A; Petrassi, HM; Petrus, MJ; Rooney, L; Schumacher, AM; Stoakley, N; Stringer, R; Tully, DC; Verkuyl, JM; Vidal, A; West, R, 2014
)
0.4
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency21.31740.01237.983543.2770AID1645841
GVesicular stomatitis virusPotency23.91850.01238.964839.8107AID1645842
Interferon betaHomo sapiens (human)Potency23.91850.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency23.91850.01238.964839.8107AID1645842
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency23.91850.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency23.91850.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)IC50 (µMol)7.33190.05102.47257.5000AID1158233; AID1549768; AID1549772; AID482134; AID482156; AID482163; AID482164; AID482165; AID640976; AID644851; AID726256
Tyrosine-protein kinase JAK1 Mus musculus (house mouse)IC50 (µMol)6.20000.01502.07676.2000AID726256
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)IC50 (µMol)200.00000.00001.104010.0000AID1421678
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)IC50 (µMol)200.00000.09001.63104.6900AID1421679
Tyrosine-protein kinase JAK3Mus musculus (house mouse)IC50 (µMol)6.20000.04801.36726.2000AID726256
Transient receptor potential cation channel subfamily A member 1Rattus norvegicus (Norway rat)IC50 (µMol)3.85000.45003.42437.5000AID640977; AID644855
Transient receptor potential cation channel subfamily M member 8Homo sapiens (human)IC50 (µMol)30.00000.02001.27553.9000AID482124
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)IC50 (µMol)20.00000.00020.606010.0000AID482132
Transient receptor potential cation channel subfamily V member 3Homo sapiens (human)IC50 (µMol)10.00003.00006.20009.4000AID482131
Transient receptor potential cation channel subfamily V member 4Homo sapiens (human)IC50 (µMol)10.00000.01802.01349.9000AID482130
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Mus musculus (house mouse)EC50 (µMol)1,000.00000.40002.771410.0000AID482135
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (149)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
neutrophil homeostasiscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP catabolic processcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
neutrophil chemotaxiscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
positive regulation of type II interferon productioncAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
positive regulation of interleukin-2 productioncAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
T cell receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
leukocyte migrationcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cellular response to lipopolysaccharidecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cellular response to xenobiotic stimuluscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cellular response to epinephrine stimuluscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
regulation of cardiac muscle cell contractioncAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
negative regulation of relaxation of cardiac musclecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
regulation of calcium ion transmembrane transport via high voltage-gated calcium channelcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP-mediated signalingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP catabolic processHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)
cAMP-mediated signalingHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
positive regulation of cold-induced thermogenesisTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
fever generationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
microglial cell activationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
peptide secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of systemic arterial blood pressureTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
lipid metabolic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chemosensory behaviorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of heart rateTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of mitochondrial membrane potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
glutamate secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of apoptotic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to peptide hormoneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
behavioral response to painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
sensory perception of mechanical stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory postsynaptic potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
smooth muscle contraction involved in micturitionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to alkaloidTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to ATPTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to tumor necrosis factorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to acidic pHTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to temperature stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of establishment of blood-brain barrierTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to capsazepineTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to nerve growth factor stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to temperature stimulusTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
negative regulation of hair cycleTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
positive regulation of calcium ion importTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to hypoxiaTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion transportTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell volume homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin filament organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell-cell junction assemblyTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
osmosensory signaling pathwayTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to mechanical stimulusTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of macrophage chemotaxisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
negative regulation of neuron projection developmentTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin cytoskeleton organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
vasopressin secretionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of microtubule depolymerizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of interleukin-6 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to insulinTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
hyperosmotic salinity responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
glucose homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of vascular permeabilityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cortical microtubule organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of striated muscle contractionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of JNK cascadeTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
microtubule polymerizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
regulation of response to osmotic stressTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of inflammatory responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
multicellular organismal-level water homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cartilage development involved in endochondral bone morphogenesisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion importTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular response to osmotic stressTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular hypotonic responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular hypotonic salinity responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of monocyte chemotactic protein-1 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of macrophage inflammatory protein 1 alpha productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of chemokine (C-C motif) ligand 5 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
blood vessel endothelial cell delaminationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion import into cytosolTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
negative regulation of brown fat cell differentiationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
regulation of aerobic respirationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 1 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (53)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase JAK1 Mus musculus (house mouse)
3',5'-cyclic-AMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
calcium channel regulator activitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
protein bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
gamma-tubulin bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
transmembrane transporter bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
metal ion bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
3',5'-cyclic-GMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
3',5'-cyclic-AMP phosphodiesterase activityHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)
metal ion bindingHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)
3',5'-cyclic-GMP phosphodiesterase activityHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
ligand-gated calcium channel activityTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
transmembrane signaling receptor activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
voltage-gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chloride channel regulator activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphatidylinositol bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphoprotein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
temperature-gated ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
actin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
osmosensor activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein kinase C bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
monoatomic cation channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
microtubule bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
lipid bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
stretch-activated, monoatomic cation-selective, calcium channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein kinase bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
SH2 domain bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
alpha-tubulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
beta-tubulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin filament bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (49)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cytosolTyrosine-protein kinase JAK1 Mus musculus (house mouse)
centrosomecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
synaptic vesiclecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
postsynaptic densitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
Z disccAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
dendritic spinecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
excitatory synapsecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
gamma-tubulin complexcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
voltage-gated calcium channel complexcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
nucleuscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
perinuclear region of cytoplasmcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cytosolHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)
perinuclear region of cytoplasmHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)
nucleusHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)
cytosolHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)
cytosolTyrosine-protein kinase JAK3Mus musculus (house mouse)
endoplasmic reticulum membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
membrane raftTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
dendritic spine membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
neuronal cell bodyTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
postsynaptic membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cytoplasmTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
lysosomeTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
receptor complexTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmic microtubuleTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
endoplasmic reticulumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
adherens junctionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
focal adhesionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ciliumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell surfaceTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
apical plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
lamellipodiumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
filopodiumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
growth coneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cortical actin cytoskeletonTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ruffle membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ciliumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (51)

Assay IDTitleYearJournalArticle
AID482134Antagonist activity at human TRPA1 channel assessed as inhibition of nifedipine-induced intracellular calcium influx2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID1421710Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 40 mg/kg, ip measured at 2 hrs post dose relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID482132Antagonist activity at human TRPV1 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID640977Antagonist activity at rat TRPA1 expressed in HEK293 cells assessed as inhibition of BITC-induced increase in intracellular calcium concentration by Fluo4-AM based fluorometric assay2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.
AID644852Antagonist activity at human TRPA1 expressed in human IMR90 cells assessed as inhibition of acrolein-induced calcium influx at 30 uM after 40 mins by fluorescence analysis2012Bioorganic & medicinal chemistry, Mar-01, Volume: 20, Issue:5
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
AID1421699Antiinflammatory activity in formalin-induced nociception Swiss CD-1 mouse model assessed as time spent on licking or biting formalin injected right hind paw during neurogenic phase at 5 mg/kg, ip measured during phase 1 (Rvb = 97 +/- 6.86 sec)2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1421679Inhibition of recombinant human PDE7A using cAMP as substrate after 10 mins by PDE-Glo Phosphodiesterase Assay2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1421711Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 40 mg/kg, ip measured at 3 hrs post dose relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID482163Antagonist activity at human TRPA1 channel assessed as inhibition of formalin-induced intracellular calcium influx2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID644851Antagonist activity at human TRPA1 expressed in human IMR90 cells assessed as inhibition of acrolein-induced calcium influx after 40 mins by fluorescence analysis2012Bioorganic & medicinal chemistry, Mar-01, Volume: 20, Issue:5
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
AID1158233Antagonist activity at TRPA1 (unknown origin)2014Journal of medicinal chemistry, Jun-26, Volume: 57, Issue:12
Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.
AID1549772Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as inhibition of CA-induced increase in calcium influx incubated for 10 mins prior to CA addition by Fluo-4-AM dye based fluorescence assayy2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID482135Activation of mouse TRPA1 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID1421678Inhibition of recombinant human PDE4B using cAMP as substrate after 10 mins by PDE-Glo Phosphodiesterase Assay2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID482131Antagonist activity at human TRPV3 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID1421677Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as decrease in flufenamic acid-evoked increase in intracellular calcium level at 1 uM measured for 180 secs with 1 sec interval by Fluo4-AM dye-based fluorescence assay relative to cont2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID644858Antagonist activity at human TRPA1 expressed in human IMR90 cells assessed as inhibition of acrolein-induced calcium influx at 3 uM after 40 mins by fluorescence analysis2012Bioorganic & medicinal chemistry, Mar-01, Volume: 20, Issue:5
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
AID1421708Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg, ip measured at 3 hrs post dose relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1421712Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, ip measured at 1 hr post dose relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1421701Antiinflammatory activity in formalin-induced nociception Swiss CD-1 mouse model assessed as time spent on licking or biting formalin injected right hind paw during neurogenic phase at 10 mg/kg, ip measured during phase 2 (Rvb = 158.3 +/- 12.34 sec)2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID726256Inhibition of human TRPA1 expressed in HEK293 cells after 10 mins by FLIPR assay2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID482165Antagonist activity at human TRPA1 channel expressed in HEK293 cells assessed as inhibition of allyl isothiocyanate-induced intracellular calcium influx by FLIPR2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID1421675Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as decrease in flufenamic acid-evoked increase in intracellular calcium level at 100 uM measured for 180 secs with 1 sec interval by Fluo4-AM dye-based fluorescence assay relative to co2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID482124Antagonist activity at human TRPM8 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID640976Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as inhibition of 5H-dibenzo[b,e]azepine-10-carboxylic acid methyl ester-induced increase in intracellular calcium by Fluo4-AM based fluorometric assay2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.
AID644856Antagonist activity at Sprague-Dawley rat TRPV1 expressed in rat DRG neurons assessed as inhibition of capsaicin-induced calcium influx after 40 mins by fluorescence analysis2012Bioorganic & medicinal chemistry, Mar-01, Volume: 20, Issue:5
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
AID1421700Antiinflammatory activity in formalin-induced nociception Swiss CD-1 mouse model assessed as time spent on licking or biting formalin injected right hind paw during neurogenic phase at 2.5 mg/kg, ip measured during phase 1 (Rvb = 97 +/- 6.86 sec)2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1421706Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg, ip measured at 1 hr post dose relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID644853Antagonist activity at Sprague-Dawley rat TRPA1 expressed in rat DRG neurons assessed as inhibition of acrolein-induced calcium influx at 3 uM after 40 mins by fluorescence analysis2012Bioorganic & medicinal chemistry, Mar-01, Volume: 20, Issue:5
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
AID1421702Antiinflammatory activity in formalin-induced nociception Swiss CD-1 mouse model assessed as time spent on licking or biting formalin injected right hind paw during neurogenic phase at 5 mg/kg, ip measured during phase 2 (Rvb = 158.3 +/- 12.34 sec)2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1421704Antiinflammatory activity in formalin-induced nociception ip dosed Swiss CD-1 mouse model assessed as time spent on licking or biting formalin injected right hind paw during neurogenic phase measured during phase 22018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1421709Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 40 mg/kg, ip measured at 1 hr post dose relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1421713Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, ip measured at 2 hrs post dose relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1549810Antagonist activity at human TRPA1 Phe909Ala mutant expressed in HEK293 cells assessed as Ca2+ influx at 100 uM by fluorescence assay2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID1421703Antiinflammatory activity in formalin-induced nociception Swiss CD-1 mouse model assessed as time spent on licking or biting formalin injected right hind paw during neurogenic phase at 2.5 mg/kg, ip measured during phase 2 (Rvb = 158.3 +/- 12.34 sec)2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1421676Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as decrease in flufenamic acid-evoked increase in intracellular calcium level at 10 uM measured for 180 secs with 1 sec interval by Fluo4-AM dye-based fluorescence assay relative to con2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID482164Antagonist activity at human TRPA1 channel expressed in HEK293 cells assessed as inhibition of cinnamaldehyde-induced intracellular calcium influx by FLIPR2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID482130Antagonist activity at human TRPV4 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID1421698Antiinflammatory activity in formalin-induced nociception Swiss CD-1 mouse model assessed as time spent on licking or biting formalin injected right hind paw during neurogenic phase at 10 mg/kg, ip measured during phase 1 (Rvb = 97 +/- 6.86 sec)2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID644855Antagonist activity at Sprague-Dawley rat TRPA1 expressed in rat DRG neurons assessed as inhibition of acrolein-induced calcium influx after 40 mins by fluorescence analysis2012Bioorganic & medicinal chemistry, Mar-01, Volume: 20, Issue:5
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
AID1421714Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, ip measured at 3 hrs post dose relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1549768Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as inhibition of AITC-induced increase in calcium influx by fluorescence analysis in presence of 5 uM AITC2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID482156Antagonist activity at human TRPA1 channel assessed as inhibition of allyl isothiocyanate-induced intracellular calcium influx2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID644854Antagonist activity at Sprague-Dawley rat TRPA1 expressed in rat DRG neurons assessed as inhibition of acrolein-induced calcium influx at 30 uM after 40 mins by fluorescence analysis2012Bioorganic & medicinal chemistry, Mar-01, Volume: 20, Issue:5
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
AID1421707Anti-inflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 20 mg/kg, ip measured at 2 hrs post dose relative to control2018European journal of medicinal chemistry, Oct-05, Volume: 158Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346556Human TRPA1 (Transient Receptor Potential channels)2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
TRPA1 mediates formalin-induced pain.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (149)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (2.01)29.6817
2010's127 (85.23)24.3611
2020's19 (12.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.28 (24.57)
Research Supply Index5.04 (2.92)
Research Growth Index6.53 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (1.96%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other150 (98.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]